BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

512 related articles for article (PubMed ID: 29320805)

  • 1. Success rate of medical thoracoscopy and talc pleurodesis in malignant pleurisy: A single-centre experience.
    Leemans J; Dooms C; Ninane V; Yserbyt J
    Respirology; 2018 Jun; 23(6):613-617. PubMed ID: 29320805
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictive value of systemic and local inflammation parameters in talc pleurodesis assessment.
    Habal P; Omran N; Jankovicova K; Krejsek J; Mandak J
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2015 Jun; 159(2):234-41. PubMed ID: 25059234
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical efficacy and safety of thoracoscopic talc pleurodesis in malignant pleural effusions.
    Kolschmann S; Ballin A; Gillissen A
    Chest; 2005 Sep; 128(3):1431-5. PubMed ID: 16162739
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Medical thoracoscopic talc pleurodesis for malignant pleural effusion: an analysis of 27 cases].
    Zhang W; Wang GF; Zhang H; Mu XD; Jin Z
    Beijing Da Xue Xue Bao Yi Xue Ban; 2008 Dec; 40(6):600-2. PubMed ID: 19088831
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [MODERN ASPECTS OF TREATMENT FOR EXUDATIVE PLEURITIS OF TUMORAL GENESIS].
    Kolesnik AP; Kajoyan AV; Kuzmenko VA
    Klin Khir; 2016; (11):71-3. PubMed ID: 30265791
    [No Abstract]   [Full Text] [Related]  

  • 6. Clinically important associations of pleurodesis success in malignant pleural effusion: Analysis of the TIME1 data set.
    Mercer RM; Macready J; Jeffries H; Speck N; Kanellakis NI; Maskell NA; Pepperell J; Saba T; West A; Ali N; Corcoran JP; Hallifax RJ; Psallidas I; Asciak R; Hassan M; Miller RF; Rahman NM
    Respirology; 2020 Jul; 25(7):750-755. PubMed ID: 31846131
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Malignant pleurisy associated with primary lung cancer well controlled by pleurodesis using distilled water.
    Sekiya M; Ishiwata T; Yoshimi K; Nagaoka T; Morio Y; Shiota S; Suzuki T; Seyama K; Takahashi K
    Intern Med; 2009; 48(12):1051-5. PubMed ID: 19525597
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Povidone-iodine pleurodesis versus talc pleurodesis in preventing recurrence of malignant pleural effusion.
    Ibrahim IM; Dokhan AL; El-Sessy AA; Eltaweel MF
    J Cardiothorac Surg; 2015 May; 10():64. PubMed ID: 25947235
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New biomarkers in the selection of patients for talcage of pleural cavity in the palliative therapy of malign pleural exudate.
    Habal P; Omran N; Chek J; Krejsek J; Mandak J
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2015 Dec; 159(4):576-81. PubMed ID: 25690520
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effectiveness of medical thoracoscopy and thoracoscopic talc poudrage in patients with exudative pleural effusion.
    Verma A; Taha A; Venkateswaran S; Tee A
    Singapore Med J; 2015 May; 56(5):268-73. PubMed ID: 26034319
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interventions for the management of malignant pleural effusions: a network meta-analysis.
    Clive AO; Jones HE; Bhatnagar R; Preston NJ; Maskell N
    Cochrane Database Syst Rev; 2016 May; 2016(5):CD010529. PubMed ID: 27155783
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thoracoscopic talc pleurodesis for malignant pleural effusion.
    Love D; White D; Kiroff G
    ANZ J Surg; 2003; 73(1-2):19-22. PubMed ID: 12534732
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The thoracoscopic talc pleurodesis with intraoperative pleural biopsy - a retrospective analysis in patients with malignant pleural effusion].
    Hoksch B; Seidel N; Beshay M; Schmid RA
    Zentralbl Chir; 2010 Feb; 135(1):54-8. PubMed ID: 20029741
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety of pleurodesis with talc poudrage in malignant pleural effusion: a prospective cohort study.
    Janssen JP; Collier G; Astoul P; Tassi GF; Noppen M; Rodriguez-Panadero F; Loddenkemper R; Herth FJ; Gasparini S; Marquette CH; Becke B; Froudarakis ME; Driesen P; Bolliger CT; Tschopp JM
    Lancet; 2007 May; 369(9572):1535-1539. PubMed ID: 17482984
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of an Indwelling Pleural Catheter vs Talc Pleurodesis on Hospitalization Days in Patients With Malignant Pleural Effusion: The AMPLE Randomized Clinical Trial.
    Thomas R; Fysh ETH; Smith NA; Lee P; Kwan BCH; Yap E; Horwood FC; Piccolo F; Lam DCL; Garske LA; Shrestha R; Kosky C; Read CA; Murray K; Lee YCG
    JAMA; 2017 Nov; 318(19):1903-1912. PubMed ID: 29164255
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early and late mortality after pleurodesis for malignant pleural effusion.
    Bernard A; de Dompsure RB; Hagry O; Favre JP
    Ann Thorac Surg; 2002 Jul; 74(1):213-7. PubMed ID: 12118761
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [VATS in malignant pleural effusions].
    Cui Y; Wang J; Liu T
    Zhonghua Wai Ke Za Zhi; 1997 Nov; 35(11):675-6. PubMed ID: 10678010
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor type influences the effectiveness of pleurodesis in malignant effusions.
    Bielsa S; Hernández P; Rodriguez-Panadero F; Taberner T; Salud A; Porcel JM
    Lung; 2011 Apr; 189(2):151-5. PubMed ID: 21331598
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thoracic Ultrasound as an Early Predictor of Pleurodesis Success in Malignant Pleural Effusion.
    Corcoran JP; Hallifax RJ; Mercer RM; Yousuf A; Asciak R; Hassan M; Piotrowska HE; Psallidas I; Rahman NM
    Chest; 2018 Nov; 154(5):1115-1120. PubMed ID: 30243566
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Talc pleurodesis as surgical palliation of patients with malignant pleural effusion. Analysis of factors affecting survival.
    Lumachi F; Mazza F; Ermani M; Chiara GB; Basso SM
    Anticancer Res; 2012 Nov; 32(11):5071-4. PubMed ID: 23155281
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.